Merck Czech Republic made a net profit of CZK 68.6 mil in 2015, up 96.7% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 68.6 mil in 2015 and an all time low of CZK 1.98 mil in 2008.
This implies return on equity of 17.8% and return on invested capital of 15.7% in 2015. That is compared to 17.3% and 11.5% average seen in the last five years.
Since 2010, net profit of the firm increased by 351% or 35.2% a year on average.
As far as Merck Czech Republic's peers are concerned, Roche Czech Republic generated ROE of 4.40% and ROCE of 2.65% in 2015, Bayer Czech Republic's profitability reached 50.6% and 29.0%, respectively. Amgen Czech Republic operated with 18.4% and 36.6% returns in 2015..